Purple Biotech LTD. revenue

Purple Biotech LTD.'s revenue was $1.0m in fiscal 2020, up 0.0% on the year before. Since fiscal 2017 ($100,000) it has grown at a compound 115.4% a year.

Revenue history

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Purple Biotech LTD.: revenue history, annual
Fiscal year	2017Dec 2017	2018Dec 2018	2019Dec 2019	2020Dec 2020
Revenue	100	1,000	1,000	1,000
Growth on the year before	—	+900.0%	0.0%	0.0%

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Revenue against peers

Biotechnology: the closest covered companies by revenue. Last twelve months.

Company	Revenue	Growth	3-year growth a year
Purple Biotech LTD.	$1.0m	0.0%	—
Shattuck Labs, Inc.	$1.0m	-66.6%	5.2%
Medicinova Inc	$920,481	875.7%	—
Longeveron Inc.	$1.2m	-42.7%	10.4%
Dare Bioscience, Inc.	$1.4m	4366.5%	—
Cartesian Therapeutics, Inc.	$1.5m	44.0%	-68.8%

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Purple Biotech LTD.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Purple Biotech LTD.